




Healthcare Industry News: vascular access
News Release - June 25, 2007
Intraosseous Device Company Vidacare(R) Appoints New CFO
Veteran Finance Executive Norma Soleno-DeVaney Brings 27 Years of ExperienceSAN ANTONIO--(HSMN NewsFeed)--Vidacare, the leading developer, manufacturer, and marketer of advanced intraosseous access technology for multiple diagnostic, monitoring and therapeutic applications, today announced the appointment of Norma Soleno-DeVaney as the company's chief financial officer.
"Ms. Soleno-DeVaney's high level of technical expertise combined with an extensive professional background in accounting makes her a critical asset to our executive team as the company continues to experience rapid growth," stated Philip W. Faris Jr., president and CEO of Vidacare. "She has proven herself in the capacity of finance executive, and now brings that tested experience to her new role as Vidacare CFO."
Over the past five years, Vidacare has experienced tremendous growth with the successful penetration of its EZ-IOŽ product into the emergency medical market, and continues to expand its product offerings in the medical device industry. Vidacare's position as an innovative medical device company was recently verified when the company was named recipient of the Vendor of The Year Award from the Independent Medical Distributor's Association.
"Vidacare is at a crucial point to truly solidify its position in the medical device market, while pushing beyond the well-known EZ-IO product into the oncology market with this exciting, intraosseous technology," said Soleno-DeVaney. "I'm anticipating the direction we can take this company in, given the great team I know I'll be working with and the cutting-edge advances we'll continue to bring to the market moving forward. This is something I'm truly honored to be a part of."
About Vidacare Corporation
VidacareŽ is the leading developer, manufacturer, and marketer of advanced intraosseous (IO) access technology for multiple diagnostic, monitoring, and therapeutic applications. The company's initial product line, the EZ-IOŽ System by Vidacare, serves the emergent care industry as the world's only lithium-battery powered drill and patented needle set for gaining immediate vascular access when conventional IV access is difficult or impossible. Vidacare's OnControl(TM) suite of hematology/oncology products includes a power driver and specially-designed needle sets for bone marrow aspiration and biopsy. The OnControl(TM) Aspiration System by Vidacare represents the first in this series of products and will be commercially available in June 2007. Headquartered in San Antonio, Texas, Vidacare was founded in 2001 and owns the exclusive rights to innovative IO technologies developed at the University of Texas Health Science Center-San Antonio. For more information, visit www.vidacare.com.
Source: Vidacare
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.